Daxor (DXR) Stock: Buy, Sell, or Hold?
DXR - Daxor Corporation Common Stock
$9.25
-0.15 (-1.60%)
▼
5d:
-7.96%
30d:
-18.79%
90d:
-15.14%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Get Alerted When DXR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
📊 MIXED SIGNALS: DXR shows conflicting indicators. Wait for confirmation before entering.
📊 MIXED SIGNALS: DXR shows conflicting indicators. Wait for confirmation before entering.
In-depth Analysis How we analyze
Valuation Analysis: DXR is currently trading at $9.25, which is considered oversold relative to its 30-day fair value range of $9.97 to $11.33.
Technical Outlook: Technically, DXR is showing sideways momentum. The price is currently testing key support at $9.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DXR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+116.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, DXR is showing sideways momentum. The price is currently testing key support at $9.24. A bounce from this level would confirm strength, while a break below could signal further downside.
Market Sentiment: DXR scores 25/100 on our bottoming-setup gauge. Note this measures entry quality, not trend direction — a low score can mean the chart is extended after a strong run (don't chase) or still falling without stabilization; better entries typically come after a pullback toward the 20-day average. Wall Street analysts see significant upside, with an average price target of $20.00 (+116.2%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$9.97 -
$11.33
Company Quality Score
34/100
(SELL)
Volume Confirmation
HIGH
Confidence Score
57.9%
All Signals
- BULLISH: Price oversold vs 30-day range
- BEARISH: Weak technical setup (25/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 116.2% below Wall St target ($20.00)
- WARNING: Composite score 34/100 in the bottom quintile — this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$9.97 -
$11.33
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$9.24
Resistance Level
$10.58
Current Trend
Sideways
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-308.33
Wall Street Target
$20.00
(+116.2%)
Revenue Growth (YoY)
25.5%
Earnings Growth (YoY)
329.3%
Profit Margin
19861.4%
Share & Embed Analysis
Last updated: October 24, 2026 6:55 AM ET
Data refreshes hourly during market hours. Next update: 7:55 AM
Data refreshes hourly during market hours. Next update: 7:55 AM
🔥 Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is DXR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Medical Instruments & Supplies Stocks
Top-rated stocks in Medical Instruments & Supplies by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
ISRG
Intuitive Surgical Inc |
STRONG BUY
34 analysts |
$479 | 37 SELL |
|
ALC
Alcon AG |
STRONG BUY
27 analysts |
$83 | 43 HOLD |
|
RGEN
Repligen Corporation |
STRONG BUY
22 analysts |
$198 | 57 HOLD |
|
WST
West Pharmaceutical Serv… |
STRONG BUY
17 analysts |
$413 | 37 SELL |
|
STVN
Stevanato Group SpA |
BUY
14 analysts |
$24 | 72 BUY |
